Joseph P Hagan's Net Worth
$1.39 Million
Who is Joseph P Hagan?
Joseph P Hagan has an estimated net worth of $1.39 Million. This is based on reported shares across multiple companies, which include Aurinia Pharmaceuticals Inc., Orexigen Therapeutics, Inc., Zosano Pharma Corp, and Regulus Therapeutics Inc..
SEC CIK
Joseph P Hagan's CIK is 0001465278
Past Insider Trading and Trends
2019 was Joseph P Hagan's most active year for acquiring shares with 10 total transactions. Joseph P Hagan's most active month to acquire stocks was the month of April. 2012 was Joseph P Hagan's most active year for disposing of shares, totalling 11 transactions. Joseph P Hagan's most active month to dispose stocks was the month of June. 2022 saw Joseph P Hagan paying a total of $224,720.00 for 2,063,345 shares, this is the most they've acquired in one year. In 2022 Joseph P Hagan cashed out on 80,000 shares for a total of $903,650.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aurinia Pharmaceuticals Inc. (AUPH) Snapshot price: $7.4
InvestorJoseph P Hagan owns 11,961 units of Common Stock which is worth $88,511.40. In the year 2022 Joseph P Hagan filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +241.74% | 8.46K |
$10.58 | -$2,877.76 | 11.96K |
May 18 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
$13.84 | -$700,450.14 | 3.5K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orexigen Therapeutics, Inc. No price found
Chief Business OfficerJoseph P Hagan owns 13,026 units of Common Stock.acquired a total of 196,980 shares in Orexigen Therapeutics, Inc. at a cost of $356,783.20, Joseph also disposed a total of 188,000 shares of Orexigen Therapeutics, Inc. equalling to $1,163,600.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +62.30% | 5K |
$4.69 | $23,450.00 | 13.03K |
Sep 15
| |||
Form 4
|
∞
| 3.98K |
$5.34 | $21,253.20 | 3.98K |
Nov 29 - Feb 7
| |||
Form 4
|
—
|
0
|
$4.73 | -$73,680.00 |
0
|
Scheduled
|
Jul 31
| ||
Form 4
|
—
|
0
|
$4.53 | -$57,400.00 |
0
|
Scheduled
|
Jul 26
| ||
Form 4
|
—
|
0
|
$4.33 | -$149,520.00 |
0
|
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
$4.22 | -$153,200.00 |
0
|
Scheduled
|
Jul 13
| ||
Form 4
|
—
|
0
|
$3.60 | -$417,720.00 |
0
|
Scheduled
|
Jun 27 - Jun 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22 - Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zosano Pharma Corp No price found
InvestorJoseph P Hagan owns 22,500 units of Common Stock. In the year 2015 Joseph P Hagan filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +200.00% | 15K |
—
|
—
| 22.5K |
Jun 10
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
Chief Executive OfficerJoseph P Hagan owns 57,112 units of Common Stock which is worth $84,525.76. From 2016 to 2024 Joseph P Hagan acquired a total of 755,403 shares in Regulus Therapeutics Inc. at a cost of $426,868.84, Joseph also disposed a total of 124,421 shares of Regulus Therapeutics Inc. equalling to $128,910.35.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| -20.34% | -14.58K |
$1.19 | -$17,358.95 | 57.11K |
Jan 18
| |||
Form 4
| +71.96% | 30K |
—
|
—
| 71.69K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +31.55% | 100K |
$0.22 | $21,520.00 | 417.01K |
Jan 12 - Jan 26
| |||
Form 4
| -1.31% | -4.19K |
$0.89 | -$3,725.54 | 316.29K |
Scheduled
|
May 17
| ||
Form 4
| +31.01% | 75.85K |
—
|
—
| 320.48K |
Apr 14
| |||
Form 4/A
| -1.67% | -4.14K |
$1.72 | -$7,127.68 | 244.63K |
Scheduled
|
Feb 16
| ||
Form 4
| -0.85% | -4.14K |
$1.72 | -$7,127.68 | 485.76K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +21.33% | 39.68K |
$0.63 | $25,002.37 | 225.67K |
Dec 4
| |||
Form 4
| -2.74% | -6.09K |
$0.52 | -$3,175.58 | 215.99K |
Scheduled
|
Nov 16
| ||
Form 4
| -1.88% | -4.25K |
$0.60 | -$2,567.80 | 222.09K |
Scheduled
|
Aug 14
| ||
Form 4
| -1.92% | -4.43K |
$0.63 | -$2,773.77 | 226.33K |
Scheduled
|
May 15
| ||
Form 4
| -1.84% | -4.32K |
$0.83 | -$3,590.65 | 230.76K |
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| -3.43% | -8.35K |
$0.97 | -$8,067.11 | 235.08K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 4
| -2.34% | -5.84K |
$0.64 | -$3,736.32 | 243.43K |
Scheduled
|
Nov 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
| -3.39% | -8.74K |
$0.68 | -$5,968.85 | 249.27K |
Scheduled
|
Oct 1
| ||
Form 4
| -1.67% | -4.38K |
$0.55 | -$2,408.87 | 258.01K |
Scheduled
|
Aug 15
| ||
Form 4
| -2.16% | -5.78K |
$1.31 | -$7,584.40 | 262.38K |
Scheduled
|
Jul 1
| ||
Form 4/A
| +105.89% | 33.19K |
$1.08 | $35,849.52 | 64.54K |
May 7
| |||
Form 4
| +125.10% | 149.03K |
$1.22 | -$47,966.15 | 268.17K |
Scheduled
|
May 14 - May 16
| ||
Form 4
| +105.89% | 33.19K |
$1.08 | $35,849.52 | 64.54K |
May 7
| |||
Form 4
| -15.71% | -5.84K |
$0.98 | -$5,731.00 | 31.35K |
Scheduled
|
Apr 1
| ||
Form 4
| +339.46% | 65K |
$0.95 | $61,750.00 | 84.15K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +1,021.42% | 219.78K |
$0.91 | $199,999.80 | 241.3K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
∞
| 10K |
$7.19 | $71,900.00 | 10K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||